Explore why tau still lacks treatments despite its critical role in Alzheimer's disease and other tauopathies.

Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are sporadic four-repeat tauopathies that have characteristic clinical and neuropathologic profiles, but also share overlapping ...

This is a randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy, safety, and pharmacokinetics of FNP-223 (oral formulation) in slowing the progression ...

In the future, movement disorder specialists are likely to develop and validate clinical diagnostic criteria for CBD and a clinical rating scale instrument using objective parameters of apraxia, eye ...

The UK charity, PSPA, which has its head office in Milton Keynes, is hosting a free online masterclass on 25 March to help ophthalmic professionals understand Progressive Supranuclear Palsy (PSP) and ...

Progressive supranuclear palsy is a rare progressive and adult-onset neurodegenerative disease that currently has no disease-modifying drug. Approximately seven in 100,000 people worldwide is affected ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Amylyx Pharmaceuticals, Inc. (AMLX) (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced the decision to discontinue the ORION program of AMX0035 (sodium ...